AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2012
Sep 20, 2012
35124_dirs_2012-09-20_6e72ae13-9783-4f67-98c1-cf523de40477.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2012-09-20
Reporting Person: LINK MAX (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-09-20 | Celsion Corporation Common Stock | M | 35000 | $2.72 | Acquired | 296025 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-09-20 | Option to purchase Celsion Corporation Common Stock | $2.72 | X | 35000 | Disposed | 2019-01-19 | Celsion Corporation Common Stock (35000) | Direct |
Footnotes
F1: The Director purchased Celsion Corporation Common Stock through the exercise of options from his January 11, 2009 Option Grant. These options were fully vested with an exercise price of $2.72 per share. The Director has no immediate intent to sell these newly acquired shares.
More from Imunon, Inc.
Capital/Financing Update
2026
Jun 4
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Capital/Financing Update
2026
Mar 23
Regulatory Filings
2026
Mar 23